Treatment of leprosy--newer concepts.
The latest time bound WHO regimens for the treatment of paucibacillary (I, TT, BT) and multibacillary leprosy is discussed. The rationale, indications of above regimens and cautions necessary are highlighted.
D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005000:Ethionamide / Q000627:therapeutic use; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D011515:Prothionamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D011515:Prothionamide; D003622:Dapsone; D002991:Clofazimine; D005000:Ethionamide; D012293:Rifampin